RT @jeffsparks: Caveats: -secondary analysis (consider exploratory) -unclear clinical significance (modest ÎeGFR) -bas
Tweet Content
Caveats:
-secondary analysis (consider exploratory)
-unclear clinical significance (modest ΔeGFR)
-baseline CrCl 40+ (do NOT use in advanced CKD)
-systemic rheumatic diseases excluded (unethical to randomize to PBO for 2 years)
-generalizability (all had CVD, M>F, mean age 66)
Show on Archive Page
On
Display in Search Results
On
PDQ
Off